LGALS1 and glioma: The authors suggested that GAL-1 may be a critical regulator of glial tumor cell migration, invasion, neoangiogenesis, and immune system evasion mechanisms and that therapeutic strategies targeting GAL-1 are a potential approach that may provide clinical benefit in addition to current treatments.